Octagon Global Regulatory Affairs Expert Nancy Smerkanich to Present at 2011 DIA India Conference
10/17/2011
- Company’s Bangalore Office Opens, Supports Global Expansion and Regional Economy -
Octagon, a leading provider of breakthrough software and services to the global life sciences industry, today announced its participation in the 6th Annual DIA Conference on Drug Discovery and Clinical Development: Convergence of Science, Medicine, and Market Access Strategies to Benefit Patients, 15-18 October 2011 in Mumbai, India. In addition to exhibiting, Octagon’s Executive Vice President, Global Regulatory Affairs, Nancy Smerkanich, will moderate and participate in a panel titled “New Electronic Systems in Ensuring Good Clinical Practice Compliance,” on 17 October 2011 from 3:30 p.m. – 5:00 p.m.
“Our involvement in the DIA Mumbai conference and Octagon’s recent expansion and office launch in Bangalore clearly demonstrate our commitment to the global life sciences industry,” said James C. Walker, chairman and CEO of Octagon. “As the company continues to grow, we look forward to advancing our position as the clinical data and regulatory experts.”
The 2011 DIA India Conference will bring together industry professionals, clinicians, patient representatives and regulatory agencies from India (CDSCO/DCGI), the United States (FDA), Europe (EMA) and emerging markets, and will provide an interactive forum for sharing information and networking.
“The needs of the global life sciences industry are perpetually evolving, and Octagon will strive to meet and exceed our clients’ expectations as they pertain to regulatory affairs and clinical operations,” said Nancy Smerkanich, executive vice president, global regulatory affairs at Octagon. “The opening of our Bangalore office is an extremely important step for Octagon, and I welcome the opportunity to support and guide our new colleagues in any way I can.”
James C. Walker and members of Octagon’s executive leadership team will be in Bangalore for the official office launch on 19 October 2011.
About Octagon Research Solutions, Inc.
Octagon is a leader in providing breakthrough software and services to the global life sciences industry. With a foundation in data standards and advanced technology, Octagon’s eCTD and CDISC solutions provide all of the resources required to optimize drug development from data collection to submission. Octagon’s unique combination of deep domain knowledge, cross-functional electronic submission expertise and holistic process approach utilizing integrated solutions, set us apart as we serve hundreds of clients on three continents. Octagon’s global headquarters are in Wayne, Pennsylvania with additional US offices in Mountain View, California. Octagon also has European offices based in London, UK, and Asia-Pacific offices in Bangalore, India. For more information, visit www.octagonresearch.com.
Octagon Clinical Research Solutions India Private Limited is a wholly owned subsidiary of Octagon Research Solutions, Inc.
Keep in touch with Octagon